| Sickle Cell Anemia |
1 |
1 |
| Genomic Medicine |
0 |
0.74 |
| Clinical Research |
0 |
0.48 |
| I-Cell Disease |
0 |
0.48 |
| Healthcare and Medical Technology |
0 |
0.46 |
| Lysosomal Storage Disease |
0 |
0.46 |
| Gene Editing |
0 |
0.29 |
| Gene Therapy |
0 |
0.29 |
| Hospital |
0 |
0.29 |
| Biologic Therapy |
0 |
0.28 |
| Blood Transfusion |
0 |
0.28 |
| Blood |
0 |
0.19 |
| Child |
0 |
0.19 |
| CRISPR |
0 |
0.19 |
| Europe |
0 |
0.19 |
| Hematology |
0 |
0.19 |
| Investment |
0 |
0.19 |
| Transfusion |
0 |
0.19 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Imbalance |
0 |
0.1 |
| New York |
0 |
0.1 |
| Pennsylvania |
0 |
0.1 |
| Thorax |
0 |
0.1 |